Kezar Life Sciences (KZR) Misses Q3 EPS by 153c
Tweet
Share
E-mailGet Alerts KZR Hot Sheet
Join SI Premium – FREE
Kezar Life Sciences (NASDAQ: KZR) reported Q3 EPS of ($1.53).
For earnings history and earnings-related data on Kezar Life Sciences (KZR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
